BioCentury
ARTICLE | Company News

CPMP recommends Merck's Emend

July 25, 2003 7:00 AM UTC

The EMEA's Committee for Proprietary Medicinal Products (CPMP) recommended approval of Emend aprepitant from Merck (MRK) to prevent nausea and vomiting associated with cisplatin-based cancer chemother...